How Biotech Startups Use Wearable Sensors for Real-World Clinical Data

Episode 52 of Biotech Business with Fexingo explores how life sciences startups are integrating wearable sensors — smartwatches, continuous glucose monitors, and patch-based ECG devices — into clinical trials to collect continuous, real-world data outside the clinic. Lucas and Luna break down the specific case of a fictional startup called VitalWave, which uses a wrist-worn sensor to capture heart rate, activity, and sleep data in a Phase 2 heart failure trial. They discuss how this approach reduces patient burden, cuts trial costs by up to 30%, and provides richer endpoints than periodic clinic visits. The hosts compare VitalWave's strategy to how Apple and Fitbit have opened their sensor platforms for research. They also address regulatory challenges: the FDA's guidance on digital health technologies and the need for sensor validation. The episode closes with a forward look at how passive monitoring might eventually replace some in-clinic assessments, especially for chronic conditions. This is a concrete, number-driven conversation about a trend reshaping drug development in 2026. #WearableSensors #ClinicalTrials #BiotechStartups #DigitalHealth #FDA #VitalWave #AppleWatch #RealWorldData #DrugDevelopment #HeartFailure #ContinuousGlucoseMonitor #ECG #RemoteMonitoring #PatientCentric #LifeSciences #Business #FexingoBusiness #BusinessPodcast Keep every episode free: buymeacoffee.com/fexingo